Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley Perlman

Showing results (261-270 of 275) with videos related to

Pageof 28
Sort By:
Emerging Infectious Diseases|April 26, 2021
Longevity of Middle East Respiratory Syndrome Coronavirus Antibody Responses in Humans, Saudi ArabiaAbeer N Alshukairi, Jincun Zhao, Maha A Al-Mozaini, et al.
Science Advances|June 17, 2021
Targeting highly pathogenic coronavirus-induced apoptosis reduces viral pathogenesis and disease severityHin Chu, Huiping Shuai, Yuxin Hou, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 18, 2021
Test-based de-isolation in COVID-19 immunocompromised patients: Cycle threshold value versus SARS-CoV-2 viral cultureAbeer N Alshukairi, Ahmed M Tolah, Ashraf Dada, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 24, 2025
SARS-CoV-2-derived RNA replicons as safe and effective vaccinesMarta Villarejo-Torres, Iván Nombela-Diaz, Diego Muñóz-Santos, et al.
Plos Pathogens|January 13, 2022
Advances and gaps in SARS-CoV-2 infection modelsCésar Muñoz-Fontela, Lina Widerspick, Randy A Albrecht, et al.
Nature Communications|January 12, 2019
SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral targetShuofeng Yuan, Hin Chu, Jasper Fuk-Woo Chan, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2018
MERS coronaviruses from camels in Africa exhibit region-dependent genetic diversityDaniel K W Chu, Kenrie P Y Hui, Ranawaka A P M Perera, et al.
Cell|July 10, 2020
Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and TreatmentJing Sun, Zhen Zhuang, Jian Zheng, et al.
Nature Microbiology|December 12, 2025
Interferon-stimulated gene GALNT2 restricts respiratory virus infectionsWei Ran, Jinghong Yang, Shi Yu, et al.
The Journal of Clinical Investigation|July 8, 2020
Kinetics of viral load and antibody response in relation to COVID-19 severityYanqun Wang, Lu Zhang, Ling Sang, et al.
Pageof 28

Showing results (261-270 of 275) with videos related to

Sort By:
Pageof 28
Emerging Infectious Diseases|April 26, 2021
Longevity of Middle East Respiratory Syndrome Coronavirus Antibody Responses in Humans, Saudi ArabiaAbeer N Alshukairi, Jincun Zhao, Maha A Al-Mozaini, et al.
Science Advances|June 17, 2021
Targeting highly pathogenic coronavirus-induced apoptosis reduces viral pathogenesis and disease severityHin Chu, Huiping Shuai, Yuxin Hou, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 18, 2021
Test-based de-isolation in COVID-19 immunocompromised patients: Cycle threshold value versus SARS-CoV-2 viral cultureAbeer N Alshukairi, Ahmed M Tolah, Ashraf Dada, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 24, 2025
SARS-CoV-2-derived RNA replicons as safe and effective vaccinesMarta Villarejo-Torres, Iván Nombela-Diaz, Diego Muñóz-Santos, et al.
Plos Pathogens|January 13, 2022
Advances and gaps in SARS-CoV-2 infection modelsCésar Muñoz-Fontela, Lina Widerspick, Randy A Albrecht, et al.
Nature Communications|January 12, 2019
SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral targetShuofeng Yuan, Hin Chu, Jasper Fuk-Woo Chan, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2018
MERS coronaviruses from camels in Africa exhibit region-dependent genetic diversityDaniel K W Chu, Kenrie P Y Hui, Ranawaka A P M Perera, et al.
Cell|July 10, 2020
Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and TreatmentJing Sun, Zhen Zhuang, Jian Zheng, et al.
Nature Microbiology|December 12, 2025
Interferon-stimulated gene GALNT2 restricts respiratory virus infectionsWei Ran, Jinghong Yang, Shi Yu, et al.
The Journal of Clinical Investigation|July 8, 2020
Kinetics of viral load and antibody response in relation to COVID-19 severityYanqun Wang, Lu Zhang, Ling Sang, et al.
Pageof 28